In The News Posted December 11, 2019 Share Posted December 11, 2019 ROSELAND, N.J., Dec. 10, 2019 /PRNewswire/ -- Novel Drug Solutions, LLC and Eye Care Northwest, PA, announce the return of their unrestricted patent rights to several awarded and pending USA and international patents previously controlled by Harrow Health, Inc. (NASDAQ: HROW formerly... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.